We're proud to announce the launch of a new website for leading clinical diagnostics company, Owlstone Medical.
Owlstone Medical recently attracted $11.55m (£9.3m) in investment to fund commercial research and development and clinical trials of a pioneering breathalyser designed to detect disease. This investment brings them closer to their mission to save 100,000 lives through the early detection of diseases such as cancer and infectious disease. The breath biopsy tool also picked up the prestigious award for Invention of the Year at the 2017 Top 50 Digital Health Awards.
Onespacemedia’s team have created a responsive platform that amplifies the brand and showcases its technologies and achievements, positioning Owlstone Medical as global leaders in the clinical diagnostics space.
Using a range of UX techniques and an intuitive navigation system visitors are guided through the site - enhancing the user experience and leveraging design and technology to achieve the company's business objectives. The site is supported by a user-friendly content management system that empowers non-technical staff to manage the site in-house.
Owlstone Medical's CEO, Billy Boyle, said "The team at Onespacemedia quickly gained a deep understanding of our business and objectives and worked collaboratively to create a digital platform that amplifies our brand, and effectively communicates our mission and intent. They were a pleasure to work with and we are thrilled with the result.”
Check out the site.